Eyal Bartfeld, DMD,Ph.D

President and CEO

Dr. Eyal Bartfeld is an entrepreneur with a diverse background in medicine, science and technology. He started Irody (Which together with Ctrlm-M health formed CareTuner). Prior to starting Irody, Dr. Bartfeld cofounded Integra5,  growing the company to 50 employees working in two sites and underwent several rounds of VC investment. Dr. Bartfeld previously founded UniTel, a developer of unified messaging. Under his guidance, the company deployed more than 300 systems worldwide and raised two rounds of financing. Both Integra5 and UniTel led to exit events.

Earlier in his career Dr. Bartfeld spent several years in academia doing brain research. This research performed at The Rockefeller University in New York and at the Weizmann Institute. His work had been published in the Proceedings of the American National Academy of Science and is routinely cited in scientific articles and text books.

Dr. Bartfeld is the inventor of 15 issued patents. He earned his PhD in Medical Informatics and a DMD from The Hebrew University of Jerusalem.

William Landman

Director

Mr. Landman is a co-founding and controlling member of MainLine Investment Partners and directs all investment, management and strategic initiatives of the organization. In addition, he is a co-founding and controlling member of Merion Realty Partners.  Mr. Landman has also been a principal and Senior Managing Director of CMS Companies for over 30 years (since 1987), and during this period has been responsible for the investment strategy of over $2 billion in private equity and real estate capital. He serves on numerous boards of private equity firms and portfolio companies associated with MainLine or CMS investments, including Zeta Global Holdings Corp. (publicly traded on NYSE). Mr. Landman also serves as an Emeritus Trustee of the Thomas Jefferson University Board of Trustees.

Prior to joining CMS, Mr. Landman was a partner in Reich & Landman with offices in Pittsburgh, PA and Sarasota, FL, with expertise in transactional corporate practices and the representation of professional athletes. Mr. Landman holds a Bachelor of Arts degree from the University of Pittsburgh and a Juris Doctor from the University of Pittsburgh School of Law.

Caryn Seebach, PsyD

VP, Clinical Implementation

Dr. Caryn Seebach is a licensed Clinical/Health Psychologist with a specialization in chronic disease management, sleep, and chronic pain. She has spent the majority of her career embedded as an allied professional within Neurology Clinics in various academic medical centers, including the Washington, DC VA Medical Center and Thomas Jefferson University Hospital in Philadelphia. In early 2020, she transitioned her clinical expertise to a broader digital health market to provide integrative health and wellness solutions for those living with headache and migraine.

Ashwini Sharan, MD

Advisory board member

Dr. Ashwini D. Sharan is a professor of Neurological Surgery and Neurology at Thomas Jefferson University, as well as the division director of Functional and Epilepsy Surgery, and the director of the Neurosurgery Residency Program. Additionally, he leads the Surgical Epilepsy program at Thomas Jefferson University.

Dr. Ashwini D. Sharan is currently serving as the Chief Medical Officer at Medtronic Neuromodulation Operating Unit.

Robert Fisher, MD

Dr. Fisher is Maslah Saul MD professor and director of the Stanford Epilepsy Center. He had numerous research awards, including from the National Institutes of Health (NIH).

He published 160 peer-reviewed articles and five books. He was named in the 1996-2013 Best Doctors in America. He received the Ambassador Award from the International League Against Epilepsy (ILAE), the 2005 American Epilepsy Society (AES) Service Award and the 2006 Annual Clinical Research Award.